Q1 2018 Holdings
Filed 2018-05-14 | 246 holdings | $8.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Celgene Corp(CELG) | COM | 151020104 | $742 | 8,314 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $745 | 14,103 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $751 | 20,456 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $754 | 6,708 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $754 | 212,882 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $755 | 46,525 | 0.0% |
| Athenex Inc(ATNXEUR) | COM | 04685N103 | $759 | 44,608 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $764 | 34,479 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $768 | 4,771 | 0.0% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $770 | 89,845 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $775 | 17,582 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $785 | 26,118 | 0.0% |
| Stemline Therapeutics Inc | COM | 85858C107 | $791 | 51,678 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $793 | 26,560 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $795 | 9,537 | 0.0% |
| Theravance Biopharma Inc(TBPH) | COM | G8807B106 | $800 | 32,989 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $810 | 2,352 | 0.0% |
| Keryx Biopharmaceuticals Inc | COM | 492515101 | $814 | 199,089 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $814 | 20,821 | 0.0% |
| Inovio Pharmaceuticals Inc | COM NEW | 45773H201 | $823 | 174,782 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $844 | 18,260 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $857 | 125,695 | 0.0% |
| Aduro Biotech Inc(ADROEUR) | COM | 00739L101 | $859 | 92,398 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $866 | 16,983 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $882 | 60,362 | 0.0% |
| Sangamo Biosciences Inc(SGMO) | COM | 800677106 | $883 | 46,449 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $885 | 58,836 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $898 | 45,820 | 0.0% |
| Intercept Pharmaceuticals in(ICPTUSD) | COM | 45845P108 | $903 | 14,681 | 0.0% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $911 | 59,014 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $915 | 17,480 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $920 | 10,029 | 0.0% |
| LA Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $928 | 31,173 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $934 | 19,331 | 0.0% |
| Retrophin Inc | COM | 761299106 | $935 | 41,803 | 0.0% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $936 | 12,943 | 0.0% |
| Avexis Inc | COM | 05366U100 | $938 | 7,590 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $946 | 12,546 | 0.0% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $951 | 47,898 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $957 | 19,602 | 0.0% |
| Achillion Pharmaceuticals in(ACHNEUR) | COM | 00448Q201 | $973 | 262,284 | 0.0% |
| Vanguard Index FDS(VNQ) | REIT ETF | 922908553 | $976 | 12,936 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $988 | 39,254 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $999 | 42,504 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $1.0K | 212,543 | 0.0% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $1.0K | 53,407 | 0.0% |
| Akcea Therapeutics Inc(AKCAEUR) | COM | 00972L107 | $1.0K | 39,351 | 0.0% |
| Acorda Therapeutics Inc | COM | 00484M106 | $1.0K | 43,653 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $1.0K | 6,334 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $1.0K | 55,283 | 0.0% |